Dose reduction of glucocorticoids in systemic lupus erythematosus

FHS
June 13, 2024
5:09 pm

Glucocorticoids are a mainstay of treatment for systemic lupus erythematosus (SLE). But due to long-term adverse effects, dose reduction is becoming a crucial part of treat-to-target management goals.

FDA accepts SFJ and SERB’s bentracimab BLA for priority review

The BLA submission is grounded on the second interim analysis results of the Phase III REVERSE-IT trial. Credit: Michal Jarmoluk from Pixabay. The US Food

August 5, 2024

Cannes Lions taps Edelman, Dentsu execs to lead the pharma, health and wellness juries

The Cannes Lions festival and award show announced that Dentsu Health’s Collette Douaihy will lead the pharma jury and Edelman’s Wendy Chan will head up

January 20, 2024

Smiths Medical recalls thousands of ventilators over fault linked to 8 serious injuries

Dive Brief: Smiths Medical is recalling more than 2,900 emergency ventilators in the U.S. after receiving reports of a fault linked to eight serious injuries,

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.